Watanabe Todd Franklin

EDGAR CIK 0001801061

Arcutis Biotherapeutics, Inc. - ARQT

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CEO Director
Reporting Person's title: President and Chief Exec
Direct Buys
2
$21,250
6,038 Shares
Direct Sells
10
($1.26) M
-106,328 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/25/2025
10b5-1
03/26/2025
Sell
-2,171 @ $17.56
 ($38,131) 925,243 (-0.23%) Direct
03/24/2025
10b5-1
03/26/2025
Sell
-1,500 @ $17.52
 ($26,282) 927,414 (-0.16%) Direct
03/17/2025
10b5-1
03/20/2025
Sell
-1,200 @ $17.61
 ($21,137) 928,914 (-0.13%) Direct
03/04/2025
03/04/2025
Sell
-4,135 @ $13.28
 ($54,930) 930,114 (-0.44%) Direct
03/03/2025
03/04/2025
Sell
-20,880 @ $13.03
 ($272,089) 934,249 (-2.19%) Direct
02/03/2025
02/04/2025
Sell
-19,301 @ $12.70
 ($245,123) 804,129 (-2.34%) Direct
12/20/2024
10b5-1
12/23/2024
Sell
-15,000 @ $15.17
 ($227,566) 823,430 (-1.79%) Direct
11/30/2024
12/03/2024
Buy
2,038 @ $7.11
 $14,482 838,430 (0.24%) Direct
11/04/2024
11/05/2024
Sell
-13,871 @ $8.68
 ($120,459) 832,392 (-1.64%) Direct
08/02/2024
10b5-1
08/05/2024
Sell
-14,487 @ $9.02
 ($130,648) 846,263 (-1.68%) Direct
05/31/2024
12/03/2024
Buy
4,000 @ $1.69
 $6,768 836,392 (0.48%) Direct
05/02/2024
10b5-1
05/03/2024
Sell
-13,783 @ $8.74
 ($120,433) 860,750 (-1.58%) Direct